CASI Pharmaceuticals's total assets for Q3 2025 were $24.46M, a decrease of -21.60% from the previous quarter. CASI total liabilities were $53.05M for the fiscal quarter, a 2.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.